Effectiveness of the nicotine inhaler for smoking cessation in an OTC setting.

OBJECTIVE: To evaluate the effectiveness of the Nicotrol nicotine inhaler as an aid to smoking cessation in over-the-counter (OTC) versus health-care-provider (HCP) conditions. METHODS: Five hundred twenty healthy smokers were randomized to the treatment conditions and followed for a year. RESULTS:...

Descripción completa

Detalles Bibliográficos
Publicado en:American Journal of Health Behavior Vol. 28; no. 4; pp. 291 - 302
Autores principales: Leischow SJ, Ranger-Moore J, Muramoto ML, Matthews E
Formato: clinical trial research tables/charts Journal Article
Publicado: PNG Publications Jul/Aug2004
Acceso en línea:Ver este registro en EBSCOhost
Descripción
Sumario:OBJECTIVE: To evaluate the effectiveness of the Nicotrol nicotine inhaler as an aid to smoking cessation in over-the-counter (OTC) versus health-care-provider (HCP) conditions. METHODS: Five hundred twenty healthy smokers were randomized to the treatment conditions and followed for a year. RESULTS: At most follow-up visits, abstinence rates for the HCP group were 2 to 3 times those observed in the OTC group. Abstinence at 1 year was.77% in the OTC condition versus 3.08% in the HCP condition [P<.01]. Inhaler use was low. CONCLUSIONS: OTC nicotine inhaler appears to be ineffective, though quit rates are improved with HCP assistance.